Nanomaterials in the application of tumor vaccines: advantages and disadvantages

References

• RosenbergSAYangJCRestifoNPCancer immunotherapy: moving beyond current vaccinesNat Med200410990991515340416
   PubMed Web of Science ®Google Scholar
• ShashidharamurthyRBozemanENPatelJKaurRMeganathanJSelvarajPImmunotherapeutic strategies for cancer treatment: a novel protein transfer approach for cancer vaccine developmentMed Res Rev20123261197121923059764
   PubMed Web of Science ®Google Scholar
• HaleDFCliftonGTSearsAKCancer vaccines: should we be targeting patients with less aggressive disease?Expert Rev Vaccines201211672173122873128
   PubMed Web of Science ®Google Scholar
• PistoiaVMorandiFPezzoloARaffaghelloLPrigioneIMYCN: from oncoprotein to tumor-associated antigenFront Oncol2012217423162796
   PubMedGoogle Scholar
• AmorijJPKerstenGFSalujaVTowards tailored vaccine delivery: needs, challenges and perspectivesJ Control Release2012161236337622245687
   PubMed Web of Science ®Google Scholar
• NasirANanotechnology in vaccine development: a step forwardJ Invest Dermatol200912951055105919369930
   PubMed Web of Science ®Google Scholar
• FryBNKalantar-ZadehKNanotechnology-Enabled SensorsNew York, NYSpringer2008
   Google Scholar
• YoonTJKimJSKimBGYuKNChoMHLeeJKMultifunctional nanoparticles possessing a “magnetic motor effect” for drug or gene deliveryAngew Chem Int Ed Engl20054471068107115635729
   PubMed Web of Science ®Google Scholar
• YannelliJRWroblewskiJMOn the road to a tumor cell vaccine: 20 years of cellular immunotherapyVaccine20042319711315519713
   PubMed Web of Science ®Google Scholar
• TangFLiLChenDMesoporous silica nanoparticles: synthesis, biocompatibility and drug deliveryAdv Mater201224121504153422378538
   PubMed Web of Science ®Google Scholar
• TanADe La PeñaHSeifalianAMThe application of exosomes as a nanoscale cancer vaccineInt J Nanomedicine2010588990021116329
   PubMed Web of Science ®Google Scholar
• MalmoJSandvigAVårumKMStrandSPNanoparticle mediated P-glycoprotein silencing for improved drug delivery across the blood-brain barrier: a siRNA-chitosan approachPLoS One201381e5418223372682
   PubMed Web of Science ®Google Scholar
• YoshiokaYYoshikawaTNabeshiHTsutsumiYRecent topics on development of nanomaterials and nano-safety scienceYakugaku Zasshi20131332149150 Japanese23370505
   PubMed Web of Science ®Google Scholar
• Monteiro-RiviereNATranCLNanotoxicology: Characterization, Dosing and Health EffectsNew York, NYInforma Healthcare2007
   Google Scholar
• ZhangWXKarnBNanoscale environmental science and technology: challenges and opportunitiesEnviron Sci Technol20053994A95A
   PubMed Web of Science ®Google Scholar
• LanoneSBoczkowskiJBiomedical applications and potential health risks of nanomaterials: molecular mechanismsCurr Mol Med20066665166317022735
   PubMed Web of Science ®Google Scholar
• HoshinoAHanadaSYamamotoKToxicity of nanocrystal quantum dots: the relevance of surface modificationsArch Toxicol201185770772021445587
   PubMed Web of Science ®Google Scholar
• MitchellLALauerFTBurchielSWMcDonaldJDMechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in miceNat Nanotechnol20094745145619581899
   PubMed Web of Science ®Google Scholar
• RenwickLCBrownDClouterADonaldsonKIncreased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle typesOccup Environ Med200461544244715090666
   PubMed Web of Science ®Google Scholar
• TerronesMTerronesHThe carbon nanocosmos: novel materials for the twenty-first centuryPhilos Transact A Math Phys Eng Sci2003361181327892806
   PubMed Web of Science ®Google Scholar
• MengJMengJDuanJCarbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapySmall2008491364137018720440
   PubMed Web of Science ®Google Scholar
• ShenHAckermanALCodyVEnhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticlesImmunology20061171788816423043
   PubMed Web of Science ®Google Scholar
• YuJSLiuGYingHYongWHBlackKLWheelerCJVaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant gliomaCancer Res200464144973497915256471
   PubMed Web of Science ®Google Scholar
• SalcedoMBercoviciNTaylorRVaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysateCancer Immunol Immunother200655781982916187085
   PubMed Web of Science ®Google Scholar
• PantarottoDPartidosCDHoebekeJImmunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responsesChem Biol2003101096196614583262
   PubMedGoogle Scholar
• WadhwaPDZielskeSPRothJCBallasCBBowmanJEGersonSLCancer gene therapy: scientific basisAnnu Rev Med20025343745211818484
   PubMed Web of Science ®Google Scholar
• MadaniSYTanADwekMSeifalianAMFunctionalization of single-walled carbon nanotubes and their binding to cancer cellsInt J Nanomedicine2012790591422412297
   PubMed Web of Science ®Google Scholar
• JovanovićSPMarkovićZMKleutDNA novel method for the functionalization of gamma-irradiated single wall carbon nanotubes with DNANanotechnology2009204444560219801777
   PubMed Web of Science ®Google Scholar
• Gomez-GualdrónDABurgosJCYuJBalbuenaPBCarbon nanotubes: engineering biomedical applicationsProg Mol Biol Transl Sci201110417524522093220
   PubMed Web of Science ®Google Scholar
• Sánchez-PomalesGSantiago-RodríguezLCabreraCRDNA-functionalized carbon nanotubes for biosensing applicationsJ Nanosci Nanotechnol2009942175218819437957
   PubMed Web of Science ®Google Scholar
• KamNWLiuZDaiHCarbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathwayAngew Chem Int Ed Engl200645457758116345107
   PubMed Web of Science ®Google Scholar
• PantarottoDBriandJPPratoMBiancoATranslocation of bioactive peptides across cell membranes by carbon nanotubesChem Commun (Camb)20041161714737310
   PubMed Web of Science ®Google Scholar
• KlumppCKostarelosKPratoMBiancoAFunctionalized carbon nanotubes as emerging nanovectors for the delivery of therapeuticsBiochim Biophys Acta20061758340441216307724
   PubMed Web of Science ®Google Scholar
• VillaCHDaoTAhearnISingle-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigensACS Nano2011575300531121682329
   PubMed Web of Science ®Google Scholar
• KostarelosKBiancoAPratoMPromises, facts and challenges for carbon nanotubes in imaging and therapeuticsNat Nanotechnol200941062763319809452
   PubMed Web of Science ®Google Scholar
• ProffittFNanotechnology. Yellow light for nanotechScience2004305568576215297636
   PubMed Web of Science ®Google Scholar
• ServiceRFNanotoxicology. Nanotechnology grows upScience200430456781732173415205504
   PubMed Web of Science ®Google Scholar
• MannaSKSarkarSBarrJSingle-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappaB in human keratinocytesNano Lett2005591676168416159204
   PubMed Web of Science ®Google Scholar
• RavichandranPBaluchamySSadanandanBMultiwalled carbon nanotubes activate NF-kappaB and AP-1 signaling pathways to induce apoptosis in rat lung epithelial cellsApoptosis201015121507151620694747
   PubMed Web of Science ®Google Scholar
• CuiDTianFOzkanCSWangMGaoHEffect of single wall carbon nanotubes on human HEK293 cellsToxicol Lett20051551738515585362
   PubMed Web of Science ®Google Scholar
• LamCWJamesJTMcCluskeyRHunterRLPulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillationToxicol Sci200477112613414514958
   PubMed Web of Science ®Google Scholar
• ShvedovaAAKisinERMercerRUnusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in miceAm J Physiol Lung Cell Mol Physiol20052895L698L70815951334
   PubMed Web of Science ®Google Scholar
• OberdörsterGSharpZAtudoreiVExtrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of ratsJ Toxicol Environ Health A200265201531154312396867
   PubMed Web of Science ®Google Scholar
• WangHWangJDengXBiodistribution of carbon single-wall carbon nanotubes in miceJ Nanosci Nanotechnol2004481019102415656196
   PubMed Web of Science ®Google Scholar
• LamCWJamesJTMcCluskeyRArepalliSHunterRLA review of carbon nanotube toxicity and assessment of potential occupational and environmental health risksCrit Rev Toxicol200636318921716686422
   PubMed Web of Science ®Google Scholar
• NelAXiaTMädlerLLiNToxic potential of materials at the nanolevelScience2006311576162262716456071
   PubMed Web of Science ®Google Scholar
• GulatiNGuptaHTwo faces of carbon nanotube: toxicities and pharmaceutical applicationsCrit Rev Ther Drug Carrier Syst2012291658822356722
   PubMed Web of Science ®Google Scholar
• ZhaoXLiuRRecent progress and perspectives on the toxicity of carbon nanotubes at organism, organ, cell, and biomacromolecule levelsEnviron Int20124024425522244841
   PubMed Web of Science ®Google Scholar
• TakegamiSKitamuraKKawadaHPreparation and characterization of a new lipid nano-emulsion containing two cosurfactants, sodium palmitate for droplet size reduction and sucrose palmitate for stability enhancementChem Pharm Bull (Tokyo)20085681097110218670109
   PubMed Web of Science ®Google Scholar
• SakaedaTHiranoKO/W lipid emulsions for parenteral drug delivery. II. Effect of composition on pharmacokinetics of incorporated drugJ Drug Target1995332212308705256
   PubMed Web of Science ®Google Scholar
• AucouturierJDupuisLGanneVAdjuvants designed for veterinary and human vaccinesVaccine20011917–192666267211257407
   PubMed Web of Science ®Google Scholar
• GeWSunYJLiYAnti-tumor immune responses of nanoemulsion-encapsulated MHS vaccineXi Bao Yu Fen Zi Mian Yi Xue Za Zhi2008245457460 Chinese18466701
   PubMedGoogle Scholar
• GeWHuPZHuangYThe antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following different administration routesOncol Rep200922491592019724873
   PubMed Web of Science ®Google Scholar
• ChangLCWuCLLiuCWChuoWHLiPCTsaiTRPreparation, characterization and cytotoxicity evaluation of tanshinone IIA nanoemulsionsJ Biomed Nanotechnol20117455856721870460
   PubMed Web of Science ®Google Scholar
• GaspariniRPozziTMontomoliEIncreased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjectsEur J Epidemiol200117213514011599686
   PubMed Web of Science ®Google Scholar
• BanzhoffANacciPPoddaAA new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysisGerontology200349317718412679609
   PubMed Web of Science ®Google Scholar
• YeJChenGSSongHPHeat shock protein 70/MAGE-1 tumor vaccine can enhance the potency of MAGE-1-specific cellular immune responses in vivoCancer Immunol Immunother200453982583415127237
   PubMed Web of Science ®Google Scholar
• MaJHSuiYFYeJHeat shock protein 70/MAGE-3 fusion protein vaccine can enhance cellular and humoral immune responses to MAGE-3 in vivoCancer Immunol Immunother200554990791415756604
   PubMed Web of Science ®Google Scholar
• GeWSuiYFWuDCMAGE-1/heat shock protein 70/MAGE-3 fusion protein vaccine in nanoemulsion enhances cellular and humoral immune responses to MAGE-1 or MAGE-3 in vivoCancer Immunol Immunother200655784184916155756
   PubMed Web of Science ®Google Scholar
• TanYYangZPengXA novel bottom-up process to produce nanoparticles containing protein and peptide for suspension in hydrofluoroalkane propellantsInt J Pharm20114131–216717321527322
   PubMed Web of Science ®Google Scholar
• BomfordRRelative adjuvant efficacy of Al(OH)3 and saponin is related to the immunogenicity of the antigenInt Arch Allergy Appl Immunol19847538081
   Google Scholar
• MesaCFernándezLEChallenges facing adjuvants for cancer immunotherapyImmunol Cell Biol200482664465015550123
   PubMed Web of Science ®Google Scholar
• LindbladEBAluminium adjuvants – in retrospect and prospectVaccine20042227–283658366815315845
   PubMed Web of Science ®Google Scholar
• ExleyCSiesjöPErikssonHThe immunobiology of aluminium adjuvants: how do they really work?Trends Immunol201031310310920153253
   PubMed Web of Science ®Google Scholar
• SunZWeiWRuiWAluminum nano particles enhance anticancer immune response induced by tumor cell vaccineCancer Nanotechnology201016369
   Google Scholar
• MaquieiraÁBrunEMGarcés-GarcíaMPuchadesRAluminum oxide nanoparticles as carriers and adjuvants for eliciting antibodies from non-immunogenic haptensAnal Chem201284219340934823005036
   PubMed Web of Science ®Google Scholar
• ZhangQLLiMQJiJWIn vivo toxicity of nano-alumina on mice neurobehavioral profiles and the potential mechanismsInt J Immunopathol Pharmacol201124Suppl 123S29S21329562
   PubMed Web of Science ®Google Scholar
• ColemanJGJohnsonDRStanleyJKAssessing the fate and effects of nano aluminum oxide in the terrestrial earthworm, Eisenia fetidaEnviron Toxicol Chem20102971575158020821608
   PubMed Web of Science ®Google Scholar
• ShiSFJiaJFGuoXKBiocompatibility of chitosan-coated iron oxide nanoparticles with osteoblast cellsInt J Nanomedicine201275593560223118539
   PubMed Web of Science ®Google Scholar
• UpadhyayaLSinghJAgarwalVTewariRPBiomedical applications of carboxymethyl chitosansCarbohydr Polym201391145246623044156
   PubMed Web of Science ®Google Scholar
• ChenMCMiFLLiaoZXRecent advances in chitosan-based nanoparticles for oral delivery of macromoleculesAdv Drug Deliv Rev11152012 [Epub ahead of print.]
   Web of Science ®Google Scholar
• IllumLJabbal-GillIHinchcliffeMFisherANDavisSSChitosan as a novel nasal delivery system for vaccinesAdv Drug Deliv Rev2001511–3819611516781
   PubMed Web of Science ®Google Scholar
• XuYDuYEffect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticlesInt J Pharm2003250121522612480287
   PubMed Web of Science ®Google Scholar
• van der LubbenIMKerstenGFretzMMBeuveryCCoos VerhoefJJungingerHEChitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in miceVaccine20032113–141400140812615436
   PubMed Web of Science ®Google Scholar
• ChenFShiZNeohKGKangETAntioxidant and antibacterial activities of eugenol and carvacrol-grafted chitosan nanoparticlesBiotechnol Bioeng20091041303919408318
   PubMed Web of Science ®Google Scholar
• van der LubbenIMVerhoefJCBorchardGJungingerHEChitosan and its derivatives in mucosal drug and vaccine deliveryEur J Pharm Sci200114320120711576824
   PubMed Web of Science ®Google Scholar
• SayinBSomavarapuSLiXWMono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine deliveryInt J Pharm20083631–213914818662762
   PubMed Web of Science ®Google Scholar
• SeferianPGMartinezMLImmune stimulating activity of two new chitosan containing adjuvant formulationsVaccine200019666166811090719
   PubMed Web of Science ®Google Scholar
• ShibataYFosterLAMetzgerWJMyrvikQNAlveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in miceInfect Immun1997655173417419125555
   PubMed Web of Science ®Google Scholar
• CalvoPRemuñan-LópezCVila-JatoJLAlonsoMJChitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccinesPharm Res19971410143114369358557
   PubMed Web of Science ®Google Scholar
• HongCWZengQAwaiting a new era of cancer immunotherapyCancer Res201272153715371922815525
   PubMed Web of Science ®Google Scholar
• KrishnamachariYGearySMLemkeCDSalemAKNanoparticle delivery systems in cancer vaccinesPharm Res201128221523620721603
   PubMed Web of Science ®Google Scholar